ADP
66
4
GLW
50
-2
SEE
42
-4
ECL
54
5
SE
65
5
ABT
57
3
KSS
32
-2
KMI
79
2
ETR
71
2
ROST
61
5
KO
44
3
RSG
53
3
STI
10
-13
DAL
64
3
PEP
32
2
NWL
49
-3
ADI
62
5
RHI
40
-3
ICE
45
3
DHI
35
4
ADP
66
4
GLW
50
-2
SEE
42
-4
ECL
54
5
SE
65
5
ABT
57
3
KSS
32
-2
KMI
79
2
ETR
71
2
ROST
61
5
KO
44
3
RSG
53
3
STI
10
-13
DAL
64
3
PEP
32
2
NWL
49
-3
ADI
62
5
RHI
40
-3
ICE
45
3
DHI
35
4
Financhill
Back

Doubleline Opportunistic Credit Fund Vs. Janux Therapeutics Industry Stock Comparison

Buy
60

DBL
Doubleline Opportunistic Credit Fund

Last Price:
$15.57
Seasonality Move:
-1.79%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Buy
60
Doubleline Opportunistic Credit Fund (DBL) is a Buy

Is Doubleline Opportunistic Credit Fund a Buy, Sell or Hold?

  • The current Doubleline Opportunistic Credit Fund [DBL] share price is $15.56. The Score for DBL is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • DBL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DBL Stock Price Chart

What is Doubleline Opportunistic Credit Fund's stock price today?

  • The Doubleline Opportunistic Credit Fund share price today is $15.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DBL is experiencing slight buying pressure.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

DBL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 55.09 Buy
Chaikin Money Flow: 12270 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.41 - 15.65) Buy
Bollinger Bands (100): (15.38 - 15.86) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

DBL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.49 Buy
20-day SMA: 15.52 Buy
50-day SMA: 15.46 Buy
200-day SMA: 15.43 Buy
8-day EMA: 15.51 Buy
20-day EMA: 15.5 Buy
50-day EMA: 15.51 Buy
200-day EMA: 15.43 Buy

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Doubleline Opportunistic Credit Fund Earnings Growth & DBL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Doubleline Opportunistic Credit Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):